{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T17:25:11Z","timestamp":1790961911420,"version":"4.1.0"},"reference-count":45,"publisher":"Wiley","issue":"S1","license":[{"start":{"date-parts":[[2026,2,15]],"date-time":"2026-02-15T00:00:00Z","timestamp":1771113600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"},{"start":{"date-parts":[[2026,2,15]],"date-time":"2026-02-15T00:00:00Z","timestamp":1771113600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Transfusion"],"published-print":{"date-parts":[[2026,5]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>RhD mismatched transfusions in RhD negative women have the potential to impact future pregnancies through alloimmunization and development of hemolytic disease of the fetus and newborn (HDFN). As use of RhD positive emergency\u2010release blood products in pediatric trauma has increased, it has become clear that a significant alloimmunization risk also exists for RhD negative girls, which has not been addressed by existing literature. This article describes a best\u2010practice guideline to manage RhD negative pediatric females who receive RhD positive transfusions.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design<\/jats:title>\n                    <jats:p>Pathology or transfusion medicine staff are notified of RhD\u2010mismatched blood transfusions and eligibility for therapy with RhIG is determined. Patients are evaluated by Pediatrics or Pediatric Hematology. These consultants will provide counseling and offer treatment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Management strategy depends on red blood cell volume (RBCv) transfused. Pediatric females who receive RBCv &lt;20% of their TBV are eligible to receive RhIG, while those who receive &gt;20% are not. Unlike in adult females, TBV calculations change with age. All should be screened for the development of anti\u2010D antibodies between 6 and 12\u2009months after transfusion, regardless of treatment with RhIG. When the patient reaches adulthood, she should be followed by ObGyn and undergo repeat antibody testing before becoming pregnant.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Protocols for the management of mismatched transfusions in RhD negative women have been established, but there are no published guidelines directing management of similar pediatric patients. The described approach provides a safe and effective framework to mitigate RhD alloimmunization risk for these pediatric patients, thereby safeguarding their future reproductive outcomes.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1111\/trf.70094","type":"journal-article","created":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T06:36:45Z","timestamp":1771223805000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Early exposure, enduring consequences: How do I manage Rh immunoglobulin prophylaxis after Rh\u2010mismatched transfusions in children?"],"prefix":"10.1111","volume":"66","author":[{"given":"Kirea","family":"Lange","sequence":"first","affiliation":[{"name":"Department of Surgery and Perioperative Care, Dell Medical School University of Texas at Austin  Austin Texas USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Bowers","sequence":"additional","affiliation":[{"name":"Department of Surgery University of Texas at San Antonio  San Antonio Texas USA"},{"name":"Residents and Fellows Trauma Advocacy Coalition  San Antonio Texas USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niruktha","family":"Raghavan","sequence":"additional","affiliation":[{"name":"Department of Surgery University of Texas at San Antonio  San Antonio Texas USA"},{"name":"Residents and Fellows Trauma Advocacy Coalition  San Antonio Texas USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah","family":"Borland","sequence":"additional","affiliation":[{"name":"Department of Surgery University of Texas at San Antonio  San Antonio Texas USA"},{"name":"Residents and Fellows Trauma Advocacy Coalition  San Antonio Texas USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leslie","family":"Greebon","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine UT Health at San Antonio  San Antonio Texas USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Leeper","sequence":"additional","affiliation":[{"name":"Trauma and Transfusion Medicine Research Center, Department of Surgery University of Pittsburgh  Pittsburgh Pennsylvania USA"},{"name":"Department of Surgery University of Pittsburgh  Pittsburgh Pennsylvania USA"},{"name":"Department of Critical Care Medicine University of Pittsburgh  Pittsburgh Pennsylvania USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Gaines","sequence":"additional","affiliation":[{"name":"Department of Surgery UT Southwestern  Dallas Texas USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donald","family":"Jenkins","sequence":"additional","affiliation":[{"name":"Department of Surgery University of Texas at San Antonio  San Antonio Texas USA"},{"name":"Residents and Fellows Trauma Advocacy Coalition  San Antonio Texas USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2026,2,15]]},"reference":[{"key":"e_1_2_8_2_1","volume-title":"StatPearls [Internet]","author":"Lacroix AE","year":"2025"},{"key":"e_1_2_8_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bglo.2025.100016"},{"key":"e_1_2_8_4_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamapediatrics.2023.1291"},{"key":"e_1_2_8_5_1","doi-asserted-by":"publisher","DOI":"10.1080\/16078454.2022.2161215"},{"key":"e_1_2_8_6_1","unstructured":"National Highway Traffic Safety Administration.Fatality Analysis Reporting System (FARS).https:\/\/www-fars.nhtsa.dot.gov\/Main\/index.aspx"},{"key":"e_1_2_8_7_1","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2023-063411"},{"key":"e_1_2_8_8_1","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2021-052739"},{"key":"e_1_2_8_9_1","doi-asserted-by":"publisher","DOI":"10.1097\/TA.0000000000003045"},{"issue":"1","key":"e_1_2_8_10_1","article-title":"Whole blood to total transfusion volume ratio in injured children: a national database analysis","volume":"53","author":"Campwala I","year":"2024","journal-title":"J Trauma Acute Care Surg"},{"key":"e_1_2_8_11_1","doi-asserted-by":"publisher","DOI":"10.1097\/SLA.0000000000005251"},{"key":"e_1_2_8_12_1","doi-asserted-by":"publisher","DOI":"10.1136\/tsaco-2023-001252"},{"key":"e_1_2_8_13_1","doi-asserted-by":"publisher","DOI":"10.1097\/TA.0000000000001905"},{"key":"e_1_2_8_14_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1537-2995.2004.03338.x"},{"key":"e_1_2_8_15_1","doi-asserted-by":"publisher","DOI":"10.1097\/TA.0000000000004382"},{"key":"e_1_2_8_16_1","doi-asserted-by":"crossref","unstructured":"YazerMH LeeperC SpinellaPC EmerySP HorvathS SeheultJN.Maternal and child life years gained by transfusing low titer group O whole blood in trauma: A computer simulation.2024;64(S2):S93\u2013S99.","DOI":"10.1111\/trf.17767"},{"key":"e_1_2_8_17_1","doi-asserted-by":"publisher","DOI":"10.1111\/trf.17807"},{"issue":"1","key":"e_1_2_8_18_1","first-page":"S320","article-title":"How I do it: an institutional protocol for the management of RhD\u2010negative women who receive RhD\u2010positive blood","volume":"65","author":"Alkhateb R","year":"2025","journal-title":"Transfusion"},{"issue":"1","key":"e_1_2_8_19_1","first-page":"S150","article-title":"Rate of RhD\u2010alloimmunization after the transfusion of multiple RhD\u2010positive primary red blood cell\u2010containing products","volume":"61","author":"Yazer MH","year":"2021","journal-title":"Transfusion"},{"issue":"3","key":"e_1_2_8_20_1","first-page":"S54","article-title":"Timing of RhD\u2010positive red blood cell administration is associated with D\u2010alloimmunization in injured patients","volume":"63","author":"Yazer MH","year":"2023","journal-title":"Transfusion"},{"key":"e_1_2_8_21_1","doi-asserted-by":"publisher","DOI":"10.1111\/trf.16964"},{"key":"e_1_2_8_22_1","unstructured":"KlinknerDB StubbsJR NeffLP.A Reemerging Role for Whole Blood in Modern Trauma Care. Mayo Clinic News Network.2021."},{"key":"e_1_2_8_23_1","doi-asserted-by":"publisher","DOI":"10.1080\/10903127.2024.2372808"},{"key":"e_1_2_8_24_1","doi-asserted-by":"publisher","DOI":"10.1002\/pd.5355"},{"key":"e_1_2_8_25_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.315.7122.1588"},{"key":"e_1_2_8_26_1","volume-title":"Rophylac (Rh0 [D] immune globulin intravenous[human]) package insert","author":"CSL Behring","year":"2012"},{"key":"e_1_2_8_27_1","doi-asserted-by":"publisher","DOI":"10.1002\/jca.21705"},{"key":"e_1_2_8_28_1","volume-title":"Henry's clinic diagnosis and management by laboratory methods","author":"McPherson R","year":"2017"},{"key":"e_1_2_8_29_1","doi-asserted-by":"publisher","DOI":"10.2146\/ajhp140288"},{"key":"e_1_2_8_30_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00493567"},{"key":"e_1_2_8_31_1","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2431-6-3"},{"key":"e_1_2_8_32_1","doi-asserted-by":"publisher","DOI":"10.1097\/MAT.0b013e3181d0c28d"},{"key":"e_1_2_8_33_1","doi-asserted-by":"publisher","DOI":"10.1111\/aas.13720"},{"key":"e_1_2_8_34_1","doi-asserted-by":"publisher","DOI":"10.1208\/s12248-021-00581-1"},{"key":"e_1_2_8_35_1","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-12-803531-3.00002-1"},{"key":"e_1_2_8_36_1","doi-asserted-by":"publisher","DOI":"10.1093\/ajcp\/110.3.281"},{"key":"e_1_2_8_37_1","doi-asserted-by":"publisher","DOI":"10.1002\/jca.20225"},{"key":"e_1_2_8_38_1","unstructured":"U.S. Food and Drug Administration.WinRho SDF [package insert].FDA.2019. Accessed January 6 2026.https:\/\/www.fda.gov\/media\/77860\/download"},{"key":"e_1_2_8_39_1","doi-asserted-by":"publisher","DOI":"10.1111\/trf.17700"},{"key":"e_1_2_8_40_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.0041-1132.2004.04161.x"},{"key":"e_1_2_8_41_1","doi-asserted-by":"publisher","DOI":"10.1111\/trf.18138"},{"key":"e_1_2_8_42_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2022.14982"},{"issue":"4","key":"e_1_2_8_43_1","first-page":"681","article-title":"Prognosis and management in subsequent Rh alloimmunized pregnancies","volume":"16","author":"Dumitru A","year":"2021","journal-title":"Maedica (Bucur)"},{"key":"e_1_2_8_44_1","volume-title":"Blood groups and red cell antigens [Internet]","author":"Dean L","year":"2005"},{"key":"e_1_2_8_45_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2023012241"},{"key":"e_1_2_8_46_1","doi-asserted-by":"publisher","DOI":"10.1097\/AOG.0000000000002528"}],"container-title":["Transfusion"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/trf.70094","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/trf.70094","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/trf.70094","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T05:21:29Z","timestamp":1779168089000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/trf.70094"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,15]]},"references-count":45,"journal-issue":{"issue":"S1","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["10.1111\/trf.70094"],"URL":"https:\/\/doi.org\/10.1111\/trf.70094","archive":["Portico"],"relation":{},"ISSN":["0041-1132","1537-2995"],"issn-type":[{"value":"0041-1132","type":"print"},{"value":"1537-2995","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,15]]},"assertion":[{"value":"2025-11-12","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-01-13","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-02-15","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}